HM Payson & Co’s IGC Pharma IGC Stock Holding History

HM Payson & Co’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-500	Closed	–	–	890
2020 Q1	$0	Hold	500	–	–	﹤0.01%	935
2019 Q4	$0	Hold	500	–	–	﹤0.01%	946
2019 Q3	$0	Hold	500	–	–	﹤0.01%	956
2019 Q2	$1K	Buy	+500	New	+$706	﹤0.01%	936

Other funds holding IGC

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

HM Payson & Co's IGC Position: Q2 2020 in Review

HM Payson & Co sold out of IGC Pharma (IGC) in Q2 2020, closing a stake of 500 shares.

HM Payson & Co first reported a position in IGC in Q2 2019 and held it in 4 quarters. The position peaked at $1K in Q2 2019. 21 funds tracked by Wall St. Rank hold IGC as of Q2 2020.

HM Payson & Co reported no remaining IGC Pharma position as of Q2 2020 after selling out during the quarter.
HM Payson & Co sold 500 IGC Pharma shares in Q2 2020.
HM Payson & Co first reported a position in IGC Pharma in Q2 2019 and held it in 4 quarters.
HM Payson & Co's IGC Pharma position peaked at $1K in Q2 2019.
21 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2020.

Based on HM Payson & Co's 13F filing for Q2 2020, filed 13 Aug 2020.